Retatrutide, the promising compound , is creating considerable excitement within the weight management space. This drug combines the mechanisms of dual GLP-1 hormone agonists , exenatide, and is exhibiting substantial efficacy in human trials . Early data suggest this treatment may lead to greater body decline than available options , potentially p